EEG complexity signatures for decoding consumer product responses
A novel EEG-based method to decode implicit consumer responses through EEG complexity signatures, offering insights into product preference and design. This approach enhances understanding of consumer behavior beyond traditional measures.
Overview
This research introduces a pioneering method using EEG complexity signatures to decode implicit consumer responses during product and packaging interactions. By recording portable frontal EEG while consumers interact with products, this technology captures neural flexibility and responses such as cognitive ease, perceived control, and sensory pleasure. These EEG complexity signatures aim to provide deeper insights into consumer preferences and decision-making, allowing companies to optimize product design and marketing strategies beyond traditional self-report and biometric measures.
Technical specifications
The core of this solution involves extracting nonlinear EEG features, including multiscale entropy, fuzzy entropy, entropy modulation, and transfer entropy, which quantify the brain's response to product experiences. These measures provide millisecond-level timing insights and capture dynamic neural adaptability. The technology is geared towards modeling EEG complexity signatures against product outcomes like perceived superiority, preference, and purchase intent. The research is currently in the initial phases of validation, with a structured plan to test and refine the methodology in collaboration with industry partners.
Technology readiness level
Currently at Technology Readiness Level 3, this solution is in the experimental proof-of-concept stage. A 6-month validation plan is in place, involving pilot trials to further test and develop the methodology with real-world product interactions, in collaboration with industry partners.
About Loma Linda University
Loma Linda University is a private, faith-based health sciences university serving the Inland Empire and Greater Los Angeles region. Integration with a major academic medical center and a children’s hospital enables rapid industry collaboration, from feasibility assessments and contracting to multi-site trials and real-world evidence studies, supported by experienced regulatory and data teams. Corporate partners benefit from access to specialty treatment environments, streamlined research administration, and recruitment across a large, diverse patient population. Research is supported by funding from the National Institutes of Health and other competitive federal sponsors. A dedicated technology transfer office manages IP protection, licensing, and startup formation.
delivered to your inbox.